Your browser doesn't support javascript.
loading
Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection.
Nakabori, Tasuku; Abe, Yutaro; Higashi, Sena; Hirao, Takeru; Kawamoto, Yasuharu; Maeda, Shingo; Daiku, Kazuma; Urabe, Makiko; Kai, Yugo; Takada, Ryoji; Yamai, Takuo; Ikezawa, Kenji; Uehara, Hiroyuki; Ohkawa, Kazuyoshi.
Afiliação
  • Nakabori T; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Abe Y; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Higashi S; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Hirao T; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Kawamoto Y; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Maeda S; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Daiku K; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Urabe M; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Kai Y; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Takada R; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Yamai T; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Ikezawa K; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Uehara H; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
  • Ohkawa K; Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan.
JGH Open ; 6(5): 309-316, 2022 May.
Article em En | MEDLINE | ID: mdl-35601125

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article